medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2023, Número 6

<< Anterior Siguiente >>

Rev Mex Urol 2023; 83 (6)


Disfunción eréctil e infecciones virales: una revisión narrativa

López-Daza JJ, Manotas-Murillo FG, Lambis-Ricardo J, Márquez-Lázaro J

Idioma: Español
Referencias bibliográficas: 48
Paginas: 1-14
Archivo PDF: 340.49 Kb.


RESUMEN

Descripción del tema: La disfunción eréctil es una condición prevalente en la población masculina, puede ser el resultado de un problema de carácter hormonal, metabólico, resultado de procesos infecciosos, o anatómicos. Las infecciones por el virus de inunodeficiencia adquirida (VIH), virus del herpes simple, zóster, virus del papiloma humano (VPH), virus linfotrópico humano tipo I (VHTL1), dengue y SARS-CoV2 se relacionan con disfunción eréctil por diferentes mecanismos fisiopatológicos. En la mayoría de los casos resultado de la interacción con el sistema inmunológico, lo cual conduce al desarrollo de una respuesta inflamatoria local o generalizada de variada intensidad.
Relevancia: Algunas infecciones por virus pueden afectar directamente los tejidos del sistema reproductor masculino y causar disfunción eréctil, debido a que estos pueden dañar los nervios y los vasos sanguíneos necesarios para lograr y mantener una erección.
Conclusión: La disfunción eréctil es de origen multifactorial, y de acuerdo con la literatura revisada puede ser desencadenada por algunas seculeas vasculares inducidas por infecciones virales, incluidas las producidas por el virus de la inmunodeficiencia adquirida (VIH), virus del herpes simple, zóster, virus del papiloma humano (VPH), virus linfotrópico humano tipo I (VHTL1), dengue y SARS-CoV2.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. López-Torres Hidalgo J. La detección de lasdisfunciones sexuales en Atención Primaria.Atencion Primaria. 2012;44(9): 525–526.https://doi.org/10.1016/j.aprim.2012.06.002.

  2. Reino DMM, Cárdenas JPT. Prevalencia ycaracterización de disfunciones sexualesmasculinas en el personal de la Unidad académicade Salud y Bienestar de la Universidad Católicade Cuenca, año 2019. Revista de la Facultad deCiencias Médicas de la Universidad de Cuenca.2020;38(1): 53–63. https://doi.org/: https://doi.org/10.18537/RFCM.38.01.08.

  3. Corona G. Erectile dysfunction and prematureejaculation: a continuum movens supportingcouple sexual dysfunction. Journal ofEndocrinological Investigation. 2022;45(11):2029–2041. https://doi.org/10.1007/s40618-022-01793-8.

  4. Kapoor R, Kapoor A. Erectile dysfunction: Apresent day coronary disease risk equivalent.Indian Journal of Medical Research. 2016;144(3):307. https://doi.org/10.4103/0971-5916.198669.

  5. Pallangyo P, Nicholaus P, Kisenge P, Mayala H,Swai N, Janabi M. A community-based study onprevalence and correlates of erectile dysfunctionamong Kinondoni District Residents, DarEs Salaam, Tanzania. Reproductive Health.2016;13(1): 140. https://doi.org/10.1186/s12978-016-0249-2.

  6. Miyata Y, Matsuo T, Nakamura Y, MitsunariK, Ohba K, Sakai H. Pathological Significanceof Macrophages in Erectile DysfunctionIncluding Peyronie’s Disease. Biomedicines.2021;9(11): 1658. https://doi.org/10.3390/biomedicines9111658.

  7. Hashimoto D, Hirashima T, YamamuraH, Kataoka T, Fujimoto K, Hyuga T, et al.Dynamic erectile responses of a novel penileorgan model utilizing TPEM†. Biology ofReproduction. 2021;104(4): 875–886. https://doi.org/10.1093/biolre/ioab011.

  8. Yafi FA, Jenkins L, Albersen M, CoronaG, Isidori AM, Goldfarb S, et al. Erectiledysfunction. Nature Reviews Disease Primers.2016;2(1): 16003. https://doi.org/10.1038/nrdp.2016.3.

  9. Gómez-Barrios JV, Gómez ME. Inhibidoresde la 5-Fosfodiesterasa (PDE-5i): Una futuraalternativa para el manejo de la aterosclerosis.AVFT – Archivos Venezolanos de Farmacología yTerapéutica. 2019;38(2).

  10. Matsui H, Sopko N, Hannan J, BivalacquaT. Pathophysiology of Erectile Dysfunction.Current Drug Targets. 2015;16(5): 411–419.https://doi.org/10.2174/138945011605150504114041 Actions.

  11. Hsieh TC, Edwards NC, Bhattacharyya SK,Nitschelm KD, Burnett AL. The Epidemic ofCOVID-19-Related Erectile Dysfunction: AScoping Review and Health Care Perspective.Sexual Medicine Reviews. 2022;10(2): 286–310.https://doi.org/10.1016/j.sxmr.2021.09.002.

  12. Tolouian R, Vahed SZ, Ghiyasvand S, TolouianA, Ardalan M. COVID-19 interactions withangiotensin-converting enzyme 2 (ACE2)and the kinin system; looking at a potentialtreatment. Journal of Renal Injury Prevention.2020;9(2): e19–e19. https://doi.org/10.34172/jrip.2020.19.

  13. Kaynar M, Gomes ALQ, Sokolakis I, Gül M.Tip of the iceberg: erectile dysfunction andCOVID-19. International Journal of ImpotenceResearch. 2022;34(2): 152–157. https://doi.org/10.1038/s41443-022-00540-0.

  14. Guo J, Sheng K, Wu S, Chen H, Xu W. AnUpdate on the Relationship of SARS-CoV-2 andMale Reproduction. Frontiers in Endocrinology.2021;12: 788321. https://doi.org/10.3389/fendo.2021.788321.

  15. José FG, González JGÁ, Molina JMC, ArnauLB, Iribarren IM, Jabaloyas JMM, et al. [SARSCoV-2 infection: implications for sexual andreproductive health. A position statementof the Asociación Española de Andrología,Medicina Sexual y Reproductiva (ASESA)].Revista internacional de andrologia. 2020;18(3):117–123. https://doi.org/10.1016/j.androl.2020.06.001.

  16. Sansone A, Jannini EA. COVID-19 and ErectileDysfunction: Endothelial Dysfunction andBeyond. The World Journal of Men’s Health.2021;39(4): 820. https://doi.org/10.5534/wjmh.210081.

  17. Mohamad NV, Wong SK, Wan Hasan WN,Jolly JJ, Nur-Farhana MF, Ima-Nirwana S,et al. The relationship between circulatingtestosterone and inflammatory cytokines inmen. The Aging Male: The Official Journal of theInternational Society for the Study of the AgingMale. 2019;22(2): 129–140. https://doi.org/10.1080/13685538.2018.1482487.

  18. Li N, Wang T, Han D. Structural, cellular andmolecular aspects of immune privilege in thetestis. Frontiers in Immunology. 2012;3. https://doi.org/10.3389/fimmu.2012.00152.

  19. Dutta S, Sengupta P. SARS-CoV-2 and MaleInfertility: Possible Multifaceted Pathology.Reproductive Sciences. 2021;28(1): 23–26.https://doi.org/10.1007/s43032-020-00261-z.

  20. Isidori AM, Giannetta E, Pofi R, Venneri MA,Gianfrilli D, Campolo F, et al. Targeting the NOcGMP-PDE5 pathway in COVID-19 infection.The DEDALO project. Andrology. 2021;9(1):33–38. https://doi.org/10.1111/andr.12837.

  21. Kharbach Y, Khallouk A. Male genital damage inCOVID-19 patients: Are available data relevant?Asian Journal of Urology. 2021;8(3): 324–326.https://doi.org/10.1016/j.ajur.2020.06.005.

  22. Yang M, Chen S, Huang B, Zhong JM, Su H,Chen YJ, et al. Pathological Findings in the Testesof COVID-19 Patients: Clinical Implications.European Urology Focus. 2020;6(5): 1124–1129.https://doi.org/10.1016/j.euf.2020.05.009.

  23. La Marca A, Busani S, Donno V, Guaraldi G,Ligabue G, Girardis M. Testicular pain as anunusual presentation of COVID-19: a brief reviewof SARS-CoV-2 and the testis. ReproductiveBiomedicine Online. 2020;41(5): 903–906.https://doi.org/10.1016/j.rbmo.2020.07.017.

  24. Abobaker A, Raba AA. Does COVID-19affect male fertility? World Journal of Urology.2021;39(3): 975–976. https://doi.org/10.1007/s00345-020-03208-w.

  25. Younis JS, Abassi Z, Skorecki K. Is there animpact of the COVID-19 pandemic on malefertility? The ACE2 connection. AmericanJournal of Physiology - Endocrinology andMetabolism. 2020;318(6): E878–E880. https://doi.org/10.1152/ajpendo.00183.2020.

  26. Rastrelli G, Di Stasi V, Inglese F, Beccaria M,Garuti M, Di Costanzo D, et al. Low testosteronelevels predict clinical adverse outcomes inSARS-CoV-2 pneumonia patients. Andrology.2021;9(1): 88–98. https://doi.org/10.1111/andr.12821.

  27. Whalen AM, Mateo CM, Growdon AS, MillerAF. Sacral Myeloradiculitis: An UncommonComplication of Genital Herpes Infection.Pediatrics. 2019;144(1): e20182631. https://doi.org/10.1542/peds.2018-2631.

  28. Paudel V. Erectile Dysfunction Secondary toHerpes Zoster. Journal of Nepal Health ResearchCouncil. 2020;17(4): 556–557. https://doi.org/10.33314/jnhrc.v17i4.2174.

  29. Rix G, Carroll D, MacFarlane J. Herpes Zosterproducing temporary erectile dysfunction.International Journal of Impotence Research.2001;13(6): 352–353. https://doi.org/10.1038/sj.ijir.3900786.

  30. Huang C -C., Chan W -L., Chen Y -C., ChenT -J., Chung C -M., Huang P -H., et al. Herpessimplex virus infection and erectile dysfunction:a nationwide population-based study. Andrology.2013;1(2): 240–244. https://doi.org/10.1111/j.2047-2927.2012.00037.x.

  31. Erol B, Avci A, Eken C, Ozgok Y. UrinaryRetention, Erectile Dysfunction and Meningitisdue to Sacral Herpes Zoster: A Case Reportand Review of the Literature. UrologiaInternationalis. 2009;82(2): 238–241. https://doi.org/10.1159/000200807.

  32. Ma BO. Association of erectile dysfunctionwith depression in patients with chronic viralhepatitis. World Journal of Gastroenterology.2015;21(18): 5641. https://doi.org/10.3748/wjg.v21.i18.5641.

  33. Kim M, Kim SY, Rou WS, Hwang SW, LeeBS. Erectile dysfunction in patients with liverdisease related to chronic hepatitis B. Clinicaland Molecular Hepatology. 2015;21(4): 352.https://doi.org/10.3350/cmh.2015.21.4.352.

  34. Hunter SS, Gadallah A, Azawi MK, Doss W.Erectile dysfunction in patients with chronichepatitis C virus infection. Arab Journal ofGastroenterology. 2014;15(1): 16–20. https://doi.org/10.1016/j.ajg.2014.01.012.

  35. De Oliveira CJV, Neto JAC, Andrade RCP,Rocha PN, De Carvalho Filho EM. Risk Factorsfor Erectile Dysfunction in Men with HTLV-1.The Journal of Sexual Medicine. 2017;14(10):1195–1200. https://doi.org/10.1016/j.jsxm.2017.08.001.

  36. Castro N, Oliveira P, Freitas D, Rodrigues W,Muniz A, Carvalho E. Erectile dysfunction andHTLV-I infection: a silent problem. InternationalJournal of Impotence Research. 2005;17(4): 364–369. https://doi.org/10.1038/sj.ijir.3901335.

  37. Bogdan AB, Silva RG, Fantin JP, Santos GG,Spessoto LC, Facio FN. Voiding and SexualDysfunction in a Young Patient After DengueFever. Journal of Endocrinology and Metabolism.2017;6(6): 187–189. https://doi.org/10.14740/jem380e.

  38. Hart TA, Mustanski B, Ryan DT, GorbachPM, Stall RD, Surkan PJ, et al. Depressionand Sexual Dysfunction Among HIV-Positiveand HIV-Negative Men Who Have Sex WithMen: Mediation by Use of Antidepressantsand Recreational Stimulants. Archives of SexualBehavior. 2015;44(2): 399–409. https://doi.org/10.1007/s10508-014-0279-1.

  39. De Ryck I, Van Laeken D, Nöstlinger C,Platteau T, Colebunders R, The EurosupportStudy Group. Sexual Satisfaction Among MenLiving with HIV in Europe. AIDS and Behavior.2012;16(1): 225–230. https://doi.org/10.1007/s10461-011-9987-x.

  40. Scanavino MDT. Sexual Dysfunctions ofHIV-Positive Men: Associated Factors,Pathophysiology Issues, and ClinicalManagement. Advances in Urology. 2011;2011:1–10. https://doi.org/10.1155/2011/854792.

  41. Asboe D, Catalan J, Mandalia S, DedesN, Florence E, Schrooten W, et al. Sexualdysfunction in HIV-positive men is multifactorial:A study of prevalence and associatedfactors. AIDS Care. 2007;19(8): 955–965.https://doi.org/10.1080/09540120701209847.

  42. Crum-Cianflone NF, Bavaro M, Hale B, AmlingC, Truett A, Brandt C, et al. Erectile Dysfunctionand Hypogonadism among Men with HIV.AIDS Patient Care and STDs. 2007;21(1): 9–19.https://doi.org/10.1089/apc.2006.0071.

  43. Juang SE, Ma KSK, Kao PE, Wei JCC, YipHT, Chou MC, et al. Human PapillomavirusInfection and the Risk of Erectile Dysfunction:A Nationwide Population-Based MatchedCohort Study. Journal of Personalized Medicine.2022;12(5): 699. https://doi.org/10.3390/jpm12050699.

  44. Ponholzer A, Temml C, Obermayr R,Wehrberger C, Madersbacher S. Is ErectileDysfunction an Indicator for Increased Risk ofCoronary Heart Disease and Stroke? EuropeanUrology. 2005;48(3): 512–518. https://doi.org/10.1016/j.eururo.2005.05.014.

  45. Winegar AL, Shepherd MD, Lawson KA,Richards KM. Comparison of the claim percentgross margin earned by Texas communityindependent pharmacies for dual-eligiblebeneficiary claims before and after MedicarePart D. Journal of the American PharmacistsAssociation. 2009;49(5): 617–622. https://doi.org/10.1331/japha.2009.08099.

  46. Rintala MAM, Greénman SE, Pöllänen PP,Suominen JJO, Syrjänen SM. Detection of highriskHPV DNA in semen and its association withthe quality of semen. International Journal ofSTD & AIDS. 2004;15(11): 740–743. https://doi.org/10.1258/0956462042395122.

  47. Kucukunal A, Altunay IK, Mercan S. SexualDysfunction in Men Suffering from GenitalWarts. The Journal of Sexual Medicine.2013;10(6): 1585–1591. https://doi.org/10.1111/jsm.12132.

  48. Yannas D, Frizza F, Vignozzi L, Corona G,Maggi M, Rastrelli G. Erectile DysfunctionIs a Hallmark of Cardiovascular Disease:Unavoidable Matter of Fact or Opportunityto Improve Men’s Health? Journal of ClinicalMedicine. 2021;10(10): 2221. https://doi.org/10.3390/jcm10102221.




2020     |     www.medigraphic.com